Navigation Links
The American Society of Hematology Announces New Honorific Award
Date:7/16/2009

WASHINGTON, July 16 /PRNewswire-USNewswire/ -- The American Society of Hematology (ASH) announces the debut of the Ernest Beutler Lecture and Prize, to be awarded at ASH's annual meeting in December. The inaugural recipients are Thomas Maniatis, PhD, of Harvard University, and Yuet Wai Kan, MD, of the University of California - San Francisco.

Established in December 2008, this award, named for the late Dr. Ernest Beutler, past president of ASH and physician-scientist for over 50 years, is a two-part lectureship intended to recognize major translational advances related to a single topic. This award honors two individuals, one who has enabled advances in basic science and another individual for achievements in clinical science or translational research. Both of this year's recipients have made seminal contributions to our understanding of the biology and diagnosis of thalassemia, with specific attention paid to the impact of molecular genetic studies of globin genes on the diagnosis and treatment of the disease.

Dr. Kan, past ASH President and prior recipient of the Dameshek Prize and Stratton Medal for his pioneering work involving the use of fetal DNA to diagnose sickle cell anemia and thalassemia, will discuss the development of prenatal and DNA diagnosis for thalassemia, reviewing current and experimental treatments, and the impact of stem cell technology on future therapy.

Dr. Maniatis, of Harvard University, will discuss the development of prenatal and DNA diagnosis for thalassemia, reviewing current and experimental treatments and the impact of stem cell technology on future therapy.

The Ernest Beutler Lecture will take place on Monday, December 7(th) from 12:30 to 1:30 p.m. in New Orleans, LA. For more information, please visit the 51st ASH Annual Meeting Web site.

To arrange an interview with an award recipient, please contact Patrick C. Irelan, ASH Communications Assistant, at 202-776-0544 or pirelan@hematology.org.

The American Society of Hematology (www.hematology.org) is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology. In late 2008, ASH launched Blood: The Vital Connection (www.bloodthevitalconnection.org), a credible online resource addressing bleeding and clotting disorders, anemia, and cancer. It provides hematologist-approved information about these common blood conditions including risk factors, preventive measures, and treatment options.


'/>"/>
SOURCE American Society of Hematology
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Michigan Chamber of Commerce Joins Americans Against Food Taxes; Calls Health Care Reform Effort a Job Killer
2. Miles To End Malaria Program Gets an Extra Burst of Speed From American Le Mans Series Founder Don Panoz
3. United American Nurses Hails House Health Care Reform Bill
4. Snoring Isn't Sexy, LLC Announces Professional Relationship with the American Sleep Apnea Association
5. American Hygiene Habits Getting Worse: International Study Reveals More Illness-Causing Germs Than Ever in American Kitchens
6. American Imaging Management Debuts Patient Safety Podcasts
7. Study finds survival rates from gastrointestinal tumors improving among African-Americans
8. National Council on Skin Cancer Prevention Encourages Americans to Obtain Vitamin D Through Diet and Supplements
9. American Academy of Dermatology Issues Updated Position Statement on Vitamin D
10. Why African-Americans are at greater risk of hypertension and kidney disease
11. American Red Cross President to Address National Press Club Luncheon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... “America On The ... identity. “America On The Brink” is the creation of published author, William Nowers. ... great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... Wesley Chapel, FL (PRWEB) , ... October 12, 2017 , ... ... Chapel is holding a treadmill relay – Miles by Moonlight to raise money for ... by donating $300 or more. , Teams will work together to keep their ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... ... presenting the latest in wound care advancements to physician colleagues, skilled nursing facility ... is titled, "Navigating the Treacherous Waters of Wound Care." , "At many of ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Oct. 2, 2017 Halo Labs announces the European launch ... called the HORIZON at MIBio 2017 in Cambridge, U.K ... visible particulate matter in biopharmaceutical samples with unprecedented speed and sensitivity ... novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/27/2017)...  Commended for their devotion to personalized service, SMP Pharmacy ... one in the South Florida Business Journal,s 50 Fastest-Growing Companies, ... list, the national specialty pharmacy has found its niche.  To ... soon be honored by SFBJ as the 2017 Power Leader ... to receive his award in October, Bardisa said of the ...
(Date:9/23/2017)... HORSHAM, Pa. , Sept. 22, 2017 ... received a complete response letter from the U.S. Food ... (BLA) seeking approval of sirukumab for the treatment of ... response letter indicates additional clinical data are needed to ... of moderately to severely active RA. ...
Breaking Medicine Technology: